Stockreport

Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients

Koninklijke Philips N.V. NY Registry Shares  (PHG) 
US:NYSE Investor Relations: philips.com/a-w/about/investor.html
PDF October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same pr [Read more]